For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope. Exciting new research ...

People with small cell lung cancer (SCLC) may develop hyperpigmentation ... SCLC can lead to ectopic adrenocorticotropic hormone (ACTH) syndrome, which, in turn, can cause hyperpigmentation ...

It also estimates that about 13% of them will get a diagnosis of small cell lung cancer (SCLC ... In people with ectopic Cushing syndrome, cancer cells produce ACTH. Elevated levels of ACTH ...

Ectopic ACTH syndrome (EAS ... Does hyperpigmentation occur in non-small cell lung cancer? Paraneoplastic syndromes, like EAS, occur more often in people with SCLC than in people with non-small ...

Paraneoplastic syndromes more commonly associated with small cell lung cancer include endocrine syndromes ... of the adrenocorticotropic hormone (ACTH), which usually controls the production ...

Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease ...

Imdelltra improved survival and quality of life versus chemotherapy as second-line treatment for small cell lung cancer, ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...

Lung cancer is the leading cause of cancer deaths among both men and women. Small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC) are the two main types of lung cancer. Most lung ...

Small-cell lung cancer (SCLC) is a deadly cancer associated with smoke exposure that has neuroendocrine (NE) cell properties and is pathologically, molecularly, biologically and clinically very ...

Paraneoplastic syndromes are a group of symptoms that happen in some people who have small-cell lung cancer (SCLC ... Hormones that tumors make, such as ACTH and ADH Analysis of the fluid ...